Pharmaceuticals, Biotechnology and Life Sciences
European site enrollment concerns grow to 85% NORTHBROOK, Ill.–(BUSINESS WIRE)–#COVID19–Over the course of just one week, US clinical research study…
ObsEva CEO Ernest Loumaye s said the instituting new measures to support the priorities of safety to manage through the COVID-19 pandemic.
The U.S. Food and Drug Administration is actively and aggressively monitoring the market for any firms marketing products with fraudulent coronavirus (COVID-19) diagnostic, prevention and treatment claims as part of our ongoing efforts to protect public health during this pandemic. As a result of these activities, the agency is beginning to see unauthorized fraudulent test kits that are being marketed to test for COVID-19 in the home.
Teva said it will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month, to meet the urgent demand for the medicine as an investigational target to treat COVID-19.
BioNTech SE said Monday its development a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease has seen rapid progress. BioNTech’s product candidate, BNT162, is a potential first-in-class mRNA vaccine in the worldwide effort against COVID-19.
John Butler, the President and Chief Executive Officer sent a message about precautions to help mitigate the spread of COVID-19…
The COVID-19 crisis continues to evolve rapidly and in recent days several governments in the markets in which Unibail-Rodamco-Westfield (“URW”)…